Companies/Quantum-Si incorporated

Company profile

Quantum-Si incorporated

NASDAQ: QSI · Healthcare · Biotechnology

PublicHQ Guilford, CTCIK 0001816431Reports USD

#767 of 1,394 Healthcare companies by revenue27th-percentile growth

EA Score

40D

FH 42DQ 33GM —SS 54

v0.1 · 55/100 weight · provisional

↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, operating margin

Methodology →

Revenue TTM

$1.9M

Rev growth YoY (TTM)

-46.2%

Net income (FY)

-$101.3M

Employees

149

Market cap

$184.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.4M$2.4M2025

Net income-$101.3M-$101.3M2025

Operating income-$116.1M-$116.1M2025

Total assets$245.6M$245.6M2025

Liabilities$25.4M$25.4M2025

Equity$220.2M$220.2M2025

Revenue trend

FY2023 – FY2025 · USD

FY23

$1.1M

FY23

$3.1M

FY24

$2.4M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Product94%

Service6%

By geography

Non-US71%

UNITED STATES29%

The read

Quantum-Si incorporated booked $2.4M in FY2025 revenue, contracting 20% year over year — slower than 73% of Healthcare companies we track, at a -4160.1% net margin.

Peers · Healthcare

Evommune, Inc.44D LENZ Therapeutics, Inc.47D Panamera Holdings Corporation31D Surrozen, Inc.30D

Key facts

CEOJeffrey Alan Hawkins

SectorHealthcare

IndustryBiotechnology

HeadquartersGuilford, CT

ExchangeNASDAQ: QSI

Employees149

IPO date2020-11-13

Latest filings

8-K2026-06-24 8-K2026-05-15 10-Q2026-05-07 8-K2026-05-07 DEF 14A2026-04-01 8-K2026-03-03 10-K2026-03-03 8-K2025-12-29

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.